Cargando…

Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?

BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tollitt, James, Allan, Stuart M., Chinnadurai, Rajkumar, Odudu, Aghogho, Hoadley, Margaret, Smith, Craig, Kalra, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767689/
https://www.ncbi.nlm.nih.gov/pubmed/35042473
http://dx.doi.org/10.1186/s12882-021-02625-2
_version_ 1784634786561654784
author Tollitt, James
Allan, Stuart M.
Chinnadurai, Rajkumar
Odudu, Aghogho
Hoadley, Margaret
Smith, Craig
Kalra, Philip A.
author_facet Tollitt, James
Allan, Stuart M.
Chinnadurai, Rajkumar
Odudu, Aghogho
Hoadley, Margaret
Smith, Craig
Kalra, Philip A.
author_sort Tollitt, James
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis CKD (ND-CKD) with and without stroke. METHODS: A propensity matched sample from > 3000 Salford Kidney Study (SKS) patients, differentiated by previous stroke at study recruitment, had stored plasma analyzed for interleukin- 6 (IL-6), Von Willebrand Factor (VWF) and C-reactive protein (CRP). Multivariable cox regression analysis investigated associations between inflammation and death, end-stage renal disease (ESRD) and future non-fatal cardiovascular events (NFCVE). RESULTS: A total of 157 previous stroke patients were compared against 162 non-stroke patients. There were no significant differences in inflammatory biomarkers between the two groups. Previous stroke was associated with greater mortality risk, hazard ratio (HR) (95% CI) was 1.45 (1.07–1.97). Higher inflammatory biomarker concentrations were independently associated with death but not ESRD or NFCVE in the total population. For each 1 standard deviation (SD) increase in log IL-6, VWF and CRP, the HR for all-cause mortality were 1.35 (1.10–1.70), 1.26 (1.05–1.51) and 1.34 (1.12–1.61), respectively. CRP retained its independent association (HR 1.47 (1.15–1.87)) with death in the stroke population. CONCLUSION: Previous stroke is an important determinant of mortality. However, the adverse combination of stroke and ND-CKD does not seem to be driven by higher levels of inflammation detected after the stroke event. Biomarkers of inflammation were associated with worse outcome in both stroke and non-stroke ND-CKD patients. TRIAL REGISTRATION: 15/NW/0818. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02625-2.
format Online
Article
Text
id pubmed-8767689
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87676892022-01-19 Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients? Tollitt, James Allan, Stuart M. Chinnadurai, Rajkumar Odudu, Aghogho Hoadley, Margaret Smith, Craig Kalra, Philip A. BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke. Stroke is also an independent risk factor for worse CKD outcomes and inflammation may contribute to this bidirectional relationship. This study aims to investigate inflammatory biomarkers in patients with non-dialysis CKD (ND-CKD) with and without stroke. METHODS: A propensity matched sample from > 3000 Salford Kidney Study (SKS) patients, differentiated by previous stroke at study recruitment, had stored plasma analyzed for interleukin- 6 (IL-6), Von Willebrand Factor (VWF) and C-reactive protein (CRP). Multivariable cox regression analysis investigated associations between inflammation and death, end-stage renal disease (ESRD) and future non-fatal cardiovascular events (NFCVE). RESULTS: A total of 157 previous stroke patients were compared against 162 non-stroke patients. There were no significant differences in inflammatory biomarkers between the two groups. Previous stroke was associated with greater mortality risk, hazard ratio (HR) (95% CI) was 1.45 (1.07–1.97). Higher inflammatory biomarker concentrations were independently associated with death but not ESRD or NFCVE in the total population. For each 1 standard deviation (SD) increase in log IL-6, VWF and CRP, the HR for all-cause mortality were 1.35 (1.10–1.70), 1.26 (1.05–1.51) and 1.34 (1.12–1.61), respectively. CRP retained its independent association (HR 1.47 (1.15–1.87)) with death in the stroke population. CONCLUSION: Previous stroke is an important determinant of mortality. However, the adverse combination of stroke and ND-CKD does not seem to be driven by higher levels of inflammation detected after the stroke event. Biomarkers of inflammation were associated with worse outcome in both stroke and non-stroke ND-CKD patients. TRIAL REGISTRATION: 15/NW/0818. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02625-2. BioMed Central 2022-01-18 /pmc/articles/PMC8767689/ /pubmed/35042473 http://dx.doi.org/10.1186/s12882-021-02625-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tollitt, James
Allan, Stuart M.
Chinnadurai, Rajkumar
Odudu, Aghogho
Hoadley, Margaret
Smith, Craig
Kalra, Philip A.
Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title_full Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title_fullStr Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title_full_unstemmed Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title_short Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
title_sort does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in ckd patients?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767689/
https://www.ncbi.nlm.nih.gov/pubmed/35042473
http://dx.doi.org/10.1186/s12882-021-02625-2
work_keys_str_mv AT tollittjames doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT allanstuartm doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT chinnadurairajkumar doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT oduduaghogho doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT hoadleymargaret doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT smithcraig doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients
AT kalraphilipa doespreviousstrokemodifytherelationshipbetweeninflammatorybiomarkersandclinicalendpointsinckdpatients